
[Financial Report Data]
China Tower (00788) announced 2026 interim results, with net profit of 7.489 billion yuan to mother, an increase of 30.1% over the previous year
Tencent Music - SW (01698) Net profit attributable to non-IFRS equity holders in the second quarter was 2.69 billion yuan, up 4.4% year on year
Master Kong Holdings (00322) announced interim results. Profit attributable to shareholders of 2,433 billion yuan increased 7.1% year over year
Yuewen Group (00772) announced interim results. Revenue of 3,531 billion yuan increased 10.68% year on year IP operating business revenue reached 41.9% year on year
HK Electric-SS (02638) Announces Interim Results Profit attributable to share joint holders of HK$1.03 billion, up 0.2% year over year
Minmetals Resources (01208) Announces Interim Results Profit attributable to equity holders increased 164% year-on-year to US$897 million
China Everbright Water (01857) announced its 2026 interim results. Profit attributable to shareholders was HK$518 million, a year-on-year decrease of 8%
Yingpu Precision (01286) announced 2026 interim results. Profit attributable to shareholders was HK$421 million, an increase of 21.6% over the previous year
Kingdee International (00268) continued to lead the market in the first half of the year with profit attributable to equity holders of about 54.497 million yuan, turning a year-on-year loss into profit
Yi Dazong (01733) is expecting mid-term net profit to exceed HK$240 million, a year-on-year increase of more than 80%
Jinchuan International (02362) Fayingxi expects profit attributable to consolidated shareholders in the medium term to be about US$30 million to US$50 million
ASIX Technology (01675) accelerated the deep integration of AI capabilities and industry scenarios to achieve revenue of about 2.198 billion yuan in the first half of the year
[Important matters]
Botai Auto Federation (02889) was designated as a leading domestic NEV company project
Zhongji Xuchuang (03308) plans to invest 24.75 million yuan to participate in Qianrong Shengrun Fund
Jinjing Xinneng (01783) plans to raise about HK$1.1 billion for MiniMax strategic subscription to increase AI computing power infrastructure layout
Shiyao Group (01093): Phase I clinical trial of SYS 6063 to treat recurrent refractory systemic lupus erythematosus was officially launched at the first center in China